Triad Investment Management Laboratory Corp Of America Holdings Transaction History

Triad Investment Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 12, 2020	SELL	$104.32 - $195.28 $960,265 - $1.8 Million	-9,205 Closed	0 $0
Q4 2019 Jan 13, 2020	SELL	$163.48 - $173.61 $390,717 - $414,927	-2,390 Reduced 20.61%	9,205 $1.56 Million
Q3 2019 Oct 17, 2019	SELL	$159.77 - $178.1 $711,775 - $793,435	-4,455 Reduced 27.76%	11,595 $1.95 Million
Q2 2019 Jul 17, 2019	SELL	$144.16 - $172.9 $17,155 - $20,575	-119 Reduced 0.74%	16,050 $2.78 Million
Q1 2019 Apr 09, 2019	BUY	$123.7 - $156.3 $2 Million - $2.53 Million	16,169 New	16,169 $2.47 Million

998

76.8M

265K

192K

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $18.3B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Triad Investment Management, based on Form 13F filings with the SEC.

Stay updated on Triad Investment Management with notifications on news.